InvestorsHub Logo
Followers 14
Posts 2874
Boards Moderated 0
Alias Born 12/23/2014

Re: mrholty post# 2152

Tuesday, 06/05/2018 1:50:43 PM

Tuesday, June 05, 2018 1:50:43 PM

Post# of 2463
mrholty As I see it, the slides are saying a large and growing market that is best met through home infusions (REPR).

The REPR product is a non electric module that provides self regulating continuous flow. Its approved for reimbursement.

As for not connecting with the market. Its too bad that there was no webinar recording. I wonder how many people attended the presentation and what was said outside in the halls.

The company needs to show bottom line results. All the excuses are taken away. No lawsuit = no legal expenses. No FDA issues = no expensive consultants. Time to deliver.